![]() |
|
|
Vol. 296, Issue 2, 612-622, February 2001
Department of Pharmacology, Toxicology, and Therapeutics,
University of Kansas Medical Center, Kansas City, Kansas (S.A.S., K.F.,
K.K.R.); and Section of Environmental Toxicology, GSF-Institut
für Toxikologie, Neuherberg, Germany (K.K.R.)
Distribution, metabolism, and excretion of monochloroacetic acid (MCA)
were examined in adult male rats at a subtoxic (10 mg/kg) and a toxic
(75 mg/kg) dose. Rats were injected i.v. with [14C]MCA
and housed individually. Urine and feces were collected. Animals were
euthanized at different time intervals after dosing and tissues
procured. Radioactivity in aliquots showed very rapid distribution of
MCA to tissues. Concentrations of MCA in plasma, liver, heart, lungs,
and brown fat paralleled each other, whereas those in brain and thymus
did not. There was no dose proportionality in tissue concentrations.
Elimination of MCA from plasma required modeling by two compartments.
Most of the radioactivity found in plasma was parent MCA. Elimination
rate constant (K10) and distribution rate
constant (K12) were greatly reduced at the
toxic dose. Elimination of the toxic dose was further retarded due to increased retention of MCA in the peripheral compartment as indicated by increased mean residence times in most tissues. A very large fraction of dose was found in the gastrointestinal tract, almost all of
which was reabsorbed. Attempts to reduce toxicity by blocking the
enterohepatic circulation with activated charcoal or cholestyramine failed. Radioactivity found in bile was associated with one metabolite more polar than the parent compound. A very large fraction of dose (73 and 59%) was found in urine, 55 to 68% of which was parent MCA. The
rate-determining step in the toxicity of MCA was identified as its
detoxification by the liver. A therapeutic approach in MCA
intoxications is suggested.
This article has been cited by other articles:
![]() |
J. Kato, T. Dote, H. Shimizu, Y. Shimbo, M. Fujihara, and K. Kono Lethal acute lung injury and hypoglycemia after subcutaneous administration of monochloroacetic acid Toxicology and Industrial Health, June 1, 2006; 22(5): 203 - 209. [Abstract] [PDF] |
||||
![]() |
T. Dote, K. Kono, K. Usuda, H. Shimizu, Y. Tanimoto, E. Dote, and S. Hayashi Systemic effects and skin injury after experimental dermal exposure to monochloroacetic acid Toxicology and Industrial Health, August 1, 2003; 19(7-10): 165 - 169. [Abstract] [PDF] |
||||
![]() |
H. Shimizu, T. Dote, K. Usuda, Y. Toshina, J. Kato, A. Sakai, E. Furuya, and K. Kono Therapeutic effects of glucose infusion on monochloroacetic acid exposure in rats Toxicology and Industrial Health, September 1, 2002; 18(8): 389 - 395. [Abstract] [PDF] |
||||
![]() |
J.-Y. Chatton, J. R. Idle, C. B. Vagbo, and P. J. Magistretti Insights into the Mechanisms of Ifosfamide Encephalopathy: Drug Metabolites Have Agonistic Effects on alpha -Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA)/Kainate Receptors and Induce Cellular Acidification in Mouse Cortical Neurons J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 1161 - 1168. [Abstract] [Full Text] [PDF] |
||||